GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zomedica Corp (AMEX:ZOM) » Definitions » Cyclically Adjusted PB Ratio

Zomedica (Zomedica) Cyclically Adjusted PB Ratio : 1.34 (As of May. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Zomedica Cyclically Adjusted PB Ratio?

As of today (2024-05-28), Zomedica's current share price is $0.1744. Zomedica's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.13. Zomedica's Cyclically Adjusted PB Ratio for today is 1.34.

The historical rank and industry rank for Zomedica's Cyclically Adjusted PB Ratio or its related term are showing as below:

ZOM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.95   Med: 1.44   Max: 1.97
Current: 1.38

During the past years, Zomedica's highest Cyclically Adjusted PB Ratio was 1.97. The lowest was 0.95. And the median was 1.44.

ZOM's Cyclically Adjusted PB Ratio is ranked better than
64.97% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs ZOM: 1.38

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zomedica's adjusted book value per share data for the three months ended in Mar. 2024 was $0.237. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.13 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zomedica Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Zomedica's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zomedica Cyclically Adjusted PB Ratio Chart

Zomedica Annual Data
Trend Feb14 Feb15 Feb16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.63

Zomedica Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 1.72 1.38 1.63 1.15

Competitive Comparison of Zomedica's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Zomedica's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zomedica's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zomedica's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zomedica's Cyclically Adjusted PB Ratio falls into.



Zomedica Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zomedica's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.1744/0.13
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zomedica's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Zomedica's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.237/131.7762*131.7762
=0.237

Current CPI (Mar. 2024) = 131.7762.

Zomedica Quarterly Data

Book Value per Share CPI Adj_Book
201405 0.113 100.373 0.148
201408 0.107 100.352 0.141
201411 0.097 99.635 0.128
201502 0.078 99.032 0.104
201505 0.073 100.333 0.096
201508 0.066 100.548 0.086
201511 0.052 100.135 0.068
201602 0.042 100.040 0.055
201606 0.026 101.688 0.034
201609 0.059 101.861 0.076
201612 0.046 101.863 0.060
201703 0.033 102.862 0.042
201706 0.048 103.349 0.061
201709 0.069 104.136 0.087
201712 0.049 104.011 0.062
201803 0.040 105.290 0.050
201806 0.050 106.317 0.062
201809 0.031 106.507 0.038
201812 0.037 105.998 0.046
201903 -0.017 107.251 -0.021
201906 -0.040 108.070 -0.049
201909 -0.064 108.329 -0.078
201912 -0.091 108.420 -0.111
202003 -0.078 108.902 -0.094
202006 0.049 108.767 0.059
202009 0.073 109.815 0.088
202012 0.080 109.897 0.096
202103 0.285 111.754 0.336
202106 0.282 114.631 0.324
202109 0.277 115.734 0.315
202112 0.276 117.630 0.309
202203 0.275 121.301 0.299
202206 0.272 125.017 0.287
202209 0.274 125.227 0.288
202212 0.273 125.222 0.287
202303 0.268 127.348 0.277
202306 0.265 128.729 0.271
202309 0.266 129.860 0.270
202312 0.245 129.419 0.249
202403 0.237 131.776 0.237

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zomedica  (AMEX:ZOM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zomedica Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Zomedica's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zomedica (Zomedica) Business Description

Traded in Other Exchanges
N/A
Address
100 Phoenix Drive, Suite 125, Ann Arbor, MI, USA, 48108
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.
Executives
Johnny D Powers director C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018
Heaton Larry C Ii officer: President C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018
Russell Kevin Klass officer: Vice President of Sales C/O ZOMEDICA CORP, PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Peter Donato officer: Chief Financial Officer 9172 ETON AVENUE, CHATSWORTH CA 91311
Pamela Nichols director 14841 EAST WILDCAT DR., SCOTTSDALE AZ 85262
Karen Dehaan-fullerton officer: Chief Counsel and Secretary C/O ZOMEDICA CORP, 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018
Anthony K Blair officer: Chief Operating Officer NEOPROBE CORPORATION, 425 METRO PLACE NORTH #300, DUBLIN OH 43017
Adrian Lock officer: VP and General Manager C/O ZOMEDICA CORP, 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018
Sean Whelan director C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Robert Cohen officer: Interim CEO C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Ann Cotter officer: Chief Financial Officer & Sec. C/O ZOMEDICA PHARMACEUTICALS CORP., 100 PHOENIX DRIVE, SUITE 180, ANN ARBOR MI 48108
Stephanie Morley officer: COO & VP of Product Dev C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Christopher Ross Macleod director C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018
Christopher Wolfenberg director C/O ZOMEDICA PHARMACEUTICALS CORP, 100 PHOENIX DRIVE, SUITE 180, ANN ARBOR MI 48108
Gerald Jr Solensky director, 10 percent owner, officer: President and CEO C/O ZOMEDICA PHARMACEUTICALS CORP., 100 PHOENIX DRIVE, SUITE 190, ANN ARBOR MI 48108